You are here

JNJ

Big Pharma CEOs get candid about pricing and M&A

Pharma Voice

Mon, 07/31/23 - 10:03 am

Alkermes, nearing oncology split, posts big Q2 sales gain after winning J&J arbitration case

Fierce Pharma

Wed, 07/26/23 - 06:37 pm

J&J, GSK's ViiV tout switching study showing patients prefer their long-acting HIV med Cabenuva over Gilead rival

Fierce Pharma

Tue, 07/25/23 - 09:20 pm

Gilead Sciences

J&J outlines exchange offer for Kenvue shares

Medical Marketing and Media

Mon, 07/24/23 - 09:39 pm

Pfizer, Gilead, GSK to Capture Growing Infectious Diseases Market as J&J Pulls Back

BioSpace

Mon, 07/24/23 - 10:26 am

infectious diseases

Gilead Sciences

J&J’s 2Q23 Results Show It’s a Force to Be Reckoned with in Medtech

Medical Devices and Diagnostics Industry

Sun, 07/23/23 - 12:40 pm

J&J flags potential interference between heart pump and TAVR stents in recall

Medtech Dive

Fri, 07/21/23 - 11:56 am

J&J Exceeds Q2 Expectations, Oncology and Immunology Top Pharma Drivers

BioSpace

Thu, 07/20/23 - 09:51 pm

Janssen’s newly-merged infectious disease and vaccine unit sees significant pipeline cuts

Fierce Biotech

Thu, 07/20/23 - 10:18 am

infectious disease

Abiomed’s Impella System Hit with Another Recall

Medical Devices and Diagnostics Industry

Wed, 07/19/23 - 05:47 pm

J&J ordered to pay mesothelioma patient $18.8M in talc case, pledges to appeal

Fierce Pharma

Wed, 07/19/23 - 11:46 am

House Judiciary Committee Probes Big Pharma’s Potential Role in COVID-19 Censorship

BioSpace

Wed, 07/19/23 - 10:23 am

Johnson & Johnson becomes 4th drugmaker to file suit against IRA's drug price negotiations

Fierce Pharma

Tue, 07/18/23 - 10:07 pm

Inflation Reduction Act

J&J touts Rybrevant win in newly diagnosed lung cancer, with key Tagrisso head-to-head readout up next

Fierce Pharma

Mon, 07/17/23 - 07:04 pm

non-small cell lung cancer

See which pharma brands are the strongest and fastest-growing in 2023

Medical Marketing and Media

Wed, 07/12/23 - 11:12 pm

J&J's Ethicon Faces Mega Electrode Recall

Medical Devices and Diagnostics Industry

Wed, 07/12/23 - 09:26 am

Janssen emerges as 11th-hour financier for Nanobiotix in $2B+ deal

Medical Marketing and Media

Tue, 07/11/23 - 11:27 pm

soft tissue sarcoma

J&J Extends Lifeline to Nanobiotix in Potential $1.8B Licensing Deal

BioSpace

Mon, 07/10/23 - 09:36 pm

head and neck cancer

Janssen’s trial of plaque psoriasis therapy meets endpoints

Clinical Trials Arena

Wed, 07/5/23 - 10:18 am

clinical trials

plaque psoriasis

Former J&J sales rep indicted on charges of defrauding Boston hospital

Medtech Dive

Thu, 06/29/23 - 11:37 am

Pages